Placebo-controlled trial of venlafaxine for the treatment of major depression.
1991
Results are presented of the first double-blind, placebo-controlled trial of a novel antidepressant venlafaxine, which preclinically has demonstrated serotonin, norepinephrine, and dopamine reuptake inhibiting effects. Sixty outpatients meeting DSM-III-R criteria for major depression were randomized
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
109
Citations
NaN
KQI